HSIC

68.99

2.21% 1.49

Handel nachbörslich: 68.99

Henry Schein Inc (HSIC)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$67.50

Offen:

$67.6

24-Stunden-Volumen:

1.89M

Relative Volume:

1.07

Marktkapitalisierung:

$8.37B

Einnahmen:

$12.50B

Nettoeinkommen (Verlust:

$314.00M

KGV:

28.27

EPS:

2.44

Netto-Cashflow:

$421.00M

1W Leistung:

+4.03%

1M Leistung:

-6.03%

6M Leistung:

-11.12%

1J Leistung:

-0.65%

1-Tages-Spanne:

$67.23

$69.10

1-Wochen-Bereich:

$64.90

$69.10

52-Wochen-Spanne:

$60.56

$82.49

Henry Schein Inc Stock (HSIC) Company Profile

Firmenname

Henry Schein Inc

Sektor

Healthcare (1161)

Branche

Medical Distribution (13)

Telefon

(631) 843-5500

Adresse

135 DURYEA RD, MELVILLE, NY

Mitarbeiter

25,000

Twitter

@henryschein

Nächster Verdiensttermin

2024-11-05

Neueste SEC-Einreichungen

HSIC's Discussions on Twitter

Vergleichen Sie HSIC mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
HSIC Henry Schein Inc	68.99	8.19B	12.50B	314.00M	421.00M	2.44
MCK Mckesson Corporation	663.17	81.97B	377.60B	3.35B	5.67B	25.08
COR Cencora Inc	291.04	56.06B	316.65B	1.91B	1.14B	9.72
CAH Cardinal Health Inc	148.12	34.92B	222.58B	1.57B	1.85B	6.45
AHG Akso Health Group Adr	1.77	741.81M	2.22M	-5.63M	-1.68M	-0.24

Henry Schein Inc Stock (HSIC) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-07-25	Herabstufung	Stifel	Buy → Hold
2025-07-14	Herabstufung	Robert W. Baird	Outperform → Neutral
2025-02-14	Eingeleitet	Wells Fargo	Equal Weight
2025-01-06	Hochstufung	BofA Securities	Underperform → Buy
2024-12-04	Eingeleitet	Mizuho	Neutral
2024-07-22	Hochstufung	Robert W. Baird	Neutral → Outperform
2024-02-26	Eingeleitet	Leerink Partners	Market Perform
2023-12-12	Hochstufung	JP Morgan	Neutral → Overweight
2023-11-10	Hochstufung	Stifel	Hold → Buy
2022-08-08	Hochstufung	UBS	Sell → Neutral
2022-07-21	Herabstufung	Goldman	Buy → Neutral
2022-06-14	Herabstufung	Robert W. Baird	Outperform → Neutral
2022-05-13	Fortgesetzt	Credit Suisse	Outperform
2022-01-31	Eingeleitet	Morgan Stanley	Underweight
2022-01-07	Hochstufung	Credit Suisse	Neutral → Outperform
2021-10-01	Fortgesetzt	Credit Suisse	Neutral
2021-02-08	Fortgesetzt	Piper Sandler	Overweight
2021-01-04	Hochstufung	Robert W. Baird	Neutral → Outperform
2020-11-03	Hochstufung	Barrington Research	Mkt Perform → Outperform
2020-05-06	Herabstufung	Barrington Research	Outperform → Mkt Perform
2020-04-07	Hochstufung	Goldman	Neutral → Buy
2020-04-02	Hochstufung	Wolfe Research	Peer Perform → Outperform
2020-01-09	Herabstufung	BofA/Merrill	Neutral → Underperform
2020-01-02	Hochstufung	Evercore ISI	Underperform → In-line
2019-08-07	Herabstufung	William Blair	Outperform → Mkt Perform
2019-05-30	Eingeleitet	Wolfe Research	Underperform
2019-05-15	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2019-04-18	Eingeleitet	Guggenheim	Buy
2019-01-17	Eingeleitet	UBS	Sell
2019-01-03	Herabstufung	Evercore ISI	In-line → Underperform
2019-01-02	Herabstufung	Robert W. Baird	Outperform → Neutral
2018-11-08	Bestätigt	Barrington Research	Outperform
2018-10-25	Herabstufung	Edward Jones	Hold → Sell
2018-10-19	Fortgesetzt	Goldman	Neutral
2018-10-04	Bestätigt	Robert W. Baird	Outperform
2018-08-07	Bestätigt	Stifel	Hold
2018-04-24	Herabstufung	Goldman	Buy → Neutral
2018-04-04	Hochstufung	Leerink Partners	Mkt Perform → Outperform

Alle ansehen

Henry Schein Inc Aktie (HSIC) Neueste Nachrichten

10:20 AM

Henry Schein says new saliva testing partnership will ‘advance prevention’ - Oral Health Group

10:20 AM

04:51 AM

The Top 5 Analyst Questions From Henry Schein’s Q2 Earnings Call - Yahoo Finance

04:51 AM

Aug 12, 2025

Stock Analysis | Henry Schein OutlookMixed Signals as Analysts and Fund Flows Diverge - AInvest

Aug 12, 2025

Oral Genome Partners with Henry Schein Nationwide - Dentistry Today

Aug 12, 2025

Aug 11, 2025

Henry Schein shares rise 1.04% after-hours after showcasing innovative solutions and sponsoring volunteer event. - AInvest

Aug 11, 2025

Aug 09, 2025

Is Henry Schein, Inc.'s (NASDAQ:HSIC) Stock Price Struggling As A Result Of Its Mixed Financials? - 富途牛牛

Aug 09, 2025

Aug 08, 2025

Henry Schein (HSIC) Q2 EPS Drops 11% - AOL.com

Aug 08, 2025

Henry Schein, Inc. Just Missed EPS By 24%: Here's What Analysts Think Will Happen Next - simplywall.st

Aug 08, 2025

Earnings Miss: Henry Schein, Inc. Missed EPS By 24% And Analysts Are Revising Their Forecasts - Yahoo Finance

Aug 08, 2025

Henry Schein Stock Falls on Q2 Earnings Miss, Revenues Top - MSN

Aug 08, 2025

Henry Schein maintains 2025 EPS guidance and targets over $100M in annual cost savings as CEO transition begins - MSN

Aug 08, 2025

Henry Schein Introduces ACCLEAN Cordless Hygiene Handpiece - Orthodontic Products

Aug 06, 2025

Henry Schein Reports Second Quarter 2025 Financial Results - Zenopa

Aug 06, 2025

Henry Schein Unveils New Cordless Hygiene Handpiece - Dentistry Today

Aug 06, 2025

Henry Schein, Inc. (NASDAQ:HSIC) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 06, 2025

Henry Schein Second Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance

Aug 06, 2025

Evercore ISI Adjusts Price Target on Henry Schein to $70 From $78, Maintains In Line Rating - MarketScreener

Aug 06, 2025

Mizuho Adjusts Price Target on Henry Schein to $74 From $76, Maintains Neutral Rating - MarketScreener

Aug 06, 2025